EyePoint
Develops sustained-release retinal therapies built around DURAVYU and Durasert E technology.
$4.51
After-hours close+0.03 (+0.74%)
At close$4.48(−3.35%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | −$0.91 | — | — |
| Aug 2026 | −$1.01 | −$1.09 | −7.9% |
| May 2026 | −$0.79 | −$0.99 | −25.3% |
| Mar 2026 | −$0.78 | −$0.81 | −3.8% |
| Nov 2025 | −$0.77 | −$0.85 | −10.4% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Sep 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Sep 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Sep 2016 | |||
| May 2016 | |||
| Feb 2016 | |||
| Nov 2015 | |||
| Sep 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | −$0.91 | — | — | $232.2K | — | — |
| Aug 5, 2026 | −$1.01 | −$1.09 | −7.9% | $451.2K | $507.0K | +12.4% |
| May 6, 2026 | −$0.79 | −$0.99 | −25.3% | $352.8K | $696.0K | +97.3% |
| Mar 4, 2026 | −$0.78 | −$0.81 | −3.8% | $994.5K | $620.0K | −37.7% |
| Nov 5, 2025 | −$0.77 | −$0.85 | −10.4% | $1.0M | $966.0K | −4.0% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 6, 2025 | ||||||
| May 7, 2025 | ||||||
| Mar 5, 2025 | ||||||
| Nov 7, 2024 | ||||||
| Aug 7, 2024 | ||||||
| May 8, 2024 | ||||||
| Mar 7, 2024 | ||||||
| Nov 1, 2023 | ||||||
| Aug 2, 2023 | ||||||
| May 3, 2023 | ||||||
| Mar 2, 2023 | ||||||
| Nov 2, 2022 | ||||||
| Aug 3, 2022 | ||||||
| May 4, 2022 | ||||||
| Mar 3, 2022 | ||||||
| Nov 3, 2021 | ||||||
| Aug 4, 2021 | ||||||
| May 5, 2021 | ||||||
| Mar 4, 2021 | ||||||
| Nov 5, 2020 | ||||||
| Aug 5, 2020 | ||||||
| May 6, 2020 | ||||||
| Mar 5, 2020 | ||||||
| Nov 7, 2019 | ||||||
| Aug 7, 2019 | ||||||
| May 8, 2019 | ||||||
| Mar 14, 2019 | ||||||
| Nov 6, 2018 | ||||||
| Sep 12, 2018 | ||||||
| May 8, 2018 | ||||||
| Feb 7, 2018 | ||||||
| Nov 7, 2017 | ||||||
| Sep 11, 2017 | ||||||
| May 4, 2017 | ||||||
| Feb 7, 2017 | ||||||
| Nov 7, 2016 | ||||||
| Sep 12, 2016 | ||||||
| May 5, 2016 | ||||||
| Feb 8, 2016 | ||||||
| Nov 5, 2015 | ||||||
| Sep 9, 2015 | ||||||